Author/Authors :
Imani، Saeed نويسنده Department of Clinical Psychology, Shahid Beheshti University, Tehran, IR Iran , , Atef-Vahid، Mohammad Kazem نويسنده Sabzevar Tarbiat Moallem University, and Mental Health Research Center and Tehran Psychiatric Institute, Iran University of Medical Sciences , , Gharraee، Banafsheh نويسنده Tehran Psychiatric Institute Iran University of Medical Sciences , , Habibi، Mojtaba نويسنده Family Research Institute, Shahid Beheshti University, Tehran, Iran Habibi, Mojtaba , Bowen، Sarah نويسنده School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada , , Noroozi، Alireza نويسنده ,
Abstract :
Background: In response to high burden of opioid abuse in Iran, Ministry of Health has launched a large-scale opioid maintenance treatment program, delivered through a network of certified drug treatment centers. To promote opioid pharmacotherapies, there is an urgent need to develop and introduce evidence-based psychosocial interventions into the network.
Patients and Methods: This is a randomized clinical trial (RCT) to investigate feasibility and effectiveness of adding mindfulness-based group therapy to opioid pharmacotherapies as compared to opioid pharmacotherapies alone. The primary outcomes were treatment retention and percentage of weekly morphine, methamphetamine, and benzodiazepine negative tests.
Discussion: This is the first RCT that explores the effectiveness of mindfulness-based relapse prevention group therapy among opioid dependent clients in Iran. The feasibility of group therapy and comparison of outcomes in intervention and control groups should be discussed in the outcome article.
